In the clinical arena, patients with hemochromatosis, in which iron overload induces robust oxidative stress, have a significantly higher prevalence of cardiomyopathy if MnSOD activity is reduced by a mutation in the Mn-SOD gene [123]. Here, SOD2 is linked to hemochromatosis type 1.